Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells (Q34689078)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells |
scientific article |
Statements
1 reference
Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells (English)
1 reference
Elena Saba
1 reference
Alessandro M Gianni
1 reference
19 April 2013
1 reference
19 April 2013
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference